Devonian Announces the Filing of a New Patent Application Related to Use of Thylakoids as Delivery System for Cannabinoïds and Other Liposoluble Molecules

41

QUEBEC–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation“) (TSXv: GSD), a clinical stage biopharmaceutical corporation, today announced that the Corporation has filed a patent application for the use of thylakoids as delivery system for cannabinoids and other liposoluble molecules for pharmaceutical and cosmetic applications. The patent application relates to thylakoids and functional derivatives, as carriers for molecules. More specifically, this invention relates to…

 

 

http://www.businesswire.com/news/home/20190605005060/en/Devonian-Announces-Filing-New-Patent-Application-Related